The incidence of brain tumours in Iran: A systematic review and meta-analysis

• Main Authors: Soheil Hassanipour, Gholamreza Namvar, Mohammad Fathalipour, Mohammad Ghorbani, Elham Abdzadeh, Saber Zafarshamspour, Shirin Riahi, Abdollah Mohammadian-Hafshejani, Hamid Salehiniya
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2019-01-01
• Series: Advances in Human Biology
• Subjects: Brain tumours; incidence; Iran; systematic review
• Online Access: http://www.aihbonline.com/article.asp?issn=2321-8568;year=2019;volume=9;issue=1;spage=2;epage=7;aulast=Hassanipour
• ISSN: 2321-8568; 2348-4691

Background: Brain tumours (BTs) constitute approximately 88% of all central nervous system tumours. The present study aimed to determine the age-standardised rate (ASR) of BTs in Iran. Methods: A comprehensive search was conducted on all studies of BTs incidence using Medline/PubMed, Scopus, Embase, Google Scholar and Web of Sciences as international databases and Scientific Information Database, MagIran, IranMedex and IranDoc as Iranian databases until April 2018. This systematic review was done based on the preferred reporting items for systematic reviews and meta-analyses. Results: The primary search yielded 312 relevant studies. A total of 17 studies were included after more detailed retrieval. The results of the random-effect model were demonstrated the ASR of BTs was 4.16 (95% confidence interval [CI], 3.20–5.12) for males and 3.40 (95% CI, 2.67–4.13) for females. Conclusion: The incidence of BTs is lower in Iran compared to other parts of the world. The incidence of nervous system cancers is increasing base on region, geographical, and economic conditions in Iran. Hence, training programmes can be considered to reduce the risk factors, complications of nervous system cancers and early diagnosis of nervous tumors.